SSTR2 antibody | knockout validation | Santa Cruz sc-365502

This is a knockout-validated antibody summary, based on the publication "The GLP1R Agonist Liraglutide Reduces Hyperglucagonemia Induced by the SGLT2 Inhibitor Dapagliflozin via Somatostatin Release", as cited below [1]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

SSTR2 antibody | knockout validation | Santa Cruz sc-365502 figure 1
Figure 1. Representative images of immunofluorescence staining for SSTR2 in SSTR2 KO mice (top panel) and WT mice (bottom panel) performed on formalin-fixed, paraffin-embedded (FFPE) tissue sections (pancreatic islets). Scale bar 100 um. From [1].
Antibody information

Mouse monoclonal IgG1 κ

Company: Santa Cruz

Antibody: SSTR2

Catalog number: sc-365502

Summary: Mouse monoclonal IgG1 κ against amino acids 320-369 mapping at the C-terminus of human SSTR2a. Recommended for detection of SSTR2a of mouse, rat and human origin by western blot, immunoprecipitation, immunofluorescence, immunohistochemistry (paraffin) and ELISA.

Validation Method

Immunohistochemistry

Sample

WT and SSTR2 KO mice pancreatic tissue.

Primary incubation

1:100 dilution.

Detection

Nikon ECLIPSE Ti microscope.

References
  1. Saponaro C, Gmyr V, Thevenet J, Moerman E, Delalleau N, Pasquetti G, et al. The GLP1R Agonist Liraglutide Reduces Hyperglucagonemia Induced by the SGLT2 Inhibitor Dapagliflozin via Somatostatin Release. Cell Rep. 2019;28:1447-1454.e4 pubmed publisher